Paper Report for: Yuki_2020_Transl.Perioper.Pain.Med_7_185
Reference
Title: Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation? Yuki K, Scholl R Ref: Transl Perioper Pain Med, 7:185, 2020 : PubMed
Cases of cardiac arrest after administration of neostigmine as a neuromuscular reversal agent have been reported in the literature. Sugammadex is a new neuromuscular reversal agent that acts via a different mechanism than acetylcholinesterase inhibitors. Here we reviewed the currently available literature on the use of sugammadex and potential considerations of using sugammadex in patients with a history of heart transplantation. Based on our currently available information, sugammadex administration in heart transplant patients should warrant similar caution and preparation for cardiovascular collapse as acetylcholinesterase inhibitors.
        
Related information
Citations formats
Yuki K, Scholl R (2020) Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation? Transl Perioper Pain Med7: 185-189
Yuki K, Scholl R (2020) Transl Perioper Pain Med7: 185-189